Author: admin

  • US pauses all immigration applications from 19 non-European countries – World

    US pauses all immigration applications from 19 non-European countries – World

    The Trump administration on Tuesday said it paused all immigration applications, including green card and US citizenship processing, filed by immigrants from 19 non-European countries, citing concerns over national security and public safety.

    The…

    Continue Reading

  • WHO issues guidelines on GLP-1 therapies for obesity treatment: Understanding the impact, safety considerations, and who can benefit – Times of India

    WHO issues guidelines on GLP-1 therapies for obesity treatment: Understanding the impact, safety considerations, and who can benefit – Times of India

    1. WHO issues guidelines on GLP-1 therapies for obesity treatment: Understanding the impact, safety considerations, and who can benefit  Times of India
    2. WHO issues global guideline on the use of GLP-1 medicines in treating obesity  World Health…

    Continue Reading

  • Anthony Edwards’ late layup forces OT, as Timberwolves edge Pelicans 149-142 – NBA

    Anthony Edwards’ late layup forces OT, as Timberwolves edge Pelicans 149-142 – NBA

    1. Anthony Edwards’ late layup forces OT, as Timberwolves edge Pelicans 149-142  NBA
    2. Timberwolves, Pelicans meet again after wild Tuesday OT affair  Field Level Media
    3. Minnesota faces New Orleans on 3-game road slide  wdtimes.com
    4. Jon Krawczynski:…

    Continue Reading

  • BlackBerry (TSX:BB) Valuation Check After 56% One-Year Rally and Recent Share Price Pullback

    BlackBerry (TSX:BB) Valuation Check After 56% One-Year Rally and Recent Share Price Pullback

    BlackBerry (TSX:BB) has quietly turned into a more interesting stock again, with shares up about 56% over the past year, even after a choppy past month. That kind of move naturally raises valuation questions.

    See our latest analysis for BlackBerry.

    Recent trading has been volatile, with a 30 day share price return of minus 16.0 percent after a strong 1 year total shareholder return of 55.77 percent. This suggests momentum is consolidating after a big run.

    If BlackBerry has you watching legacy names reinvent themselves, it could be worth scanning other high growth tech and AI stocks that are shaping the next phase of digital security and software.

    With revenues back to modest growth, a small profit on the books, and shares now trading almost exactly at analyst targets, the key question is simple: Is BlackBerry still mispriced, or is the market already baking in its next chapter?

    On conventional metrics, BlackBerry looks richly priced, with the stock trading at a Price to Earnings ratio of 121.6 times its earnings at the last close of CA$5.67.

    The price to earnings multiple compares what investors are willing to pay today for each dollar of current earnings, a common yardstick for mature and emerging software names alike. For a company that has only recently turned profitable, a lofty multiple usually implies investors are banking on strong future profit growth rather than current results.

    BlackBerry’s valuation premium is clear, with its 121.6 times earnings multiple towering over the Canadian Software industry average of 50.7 times and the estimated fair Price to Earnings ratio of 36.7 times. That gap suggests the market is assigning a far higher growth or quality premium than both peers and the SWS fair ratio model indicate, and it highlights how far the multiple could compress if sentiment or growth expectations cool.

    Explore the SWS fair ratio for BlackBerry

    Result: Price-to-Earnings of 121.6x (OVERVALUED)

    However, BlackBerry still faces execution risk in monetising QNX and IVY, and any slowdown in cybersecurity demand could quickly pressure its premium valuation.

    Find out about the key risks to this BlackBerry narrative.

    While earnings multiples flag BlackBerry as expensive, our DCF model tells a different story. On that view, the shares trade about 84.9% below an estimated fair value of roughly CA$37.64, which implies the market could be deeply discounting its long term cash flow potential. Which lens do you trust more?

    Look into how the SWS DCF model arrives at its fair value.

    BB Discounted Cash Flow as at Dec 2025

    Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out BlackBerry for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 933 undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match – so you never miss a potential opportunity.

    If you see the story differently or want to dig into the numbers yourself, you can craft a personalized view in just a few minutes with Do it your way.

    A great starting point for your BlackBerry research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.

    Put your research momentum to work now, or risk missing opportunities, by scanning focused stock shortlists built from real fundamentals, growth profiles, and risk checks.

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

    Companies discussed in this article include BB.TO.

    Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

    Continue Reading

  • Sydney Sweeney, Amanda Seyfried & More At NYC Screening

    Sydney Sweeney, Amanda Seyfried & More At NYC Screening

    Sydney Sweeney and Amanda Seyfried made an appearance at The Housemaid screening in New York City on Tuesday, December 2.

    The stars of the Lionsgate psychological thriller directed by Paul Feig walked the red carpet at 787 Seventh…

    Continue Reading

  • ASX outage deepens investors' doubts over tech overhaul – Reuters

    1. ASX outage deepens investors’ doubts over tech overhaul  Reuters
    2. Our stock exchange has a nincompoop problem!  Switzer Daily
    3. ‘I feel sorry for them’: Ten Cap founder on ASX’s woes  investordaily.com.au
    4. VIDEO: Monday Finance with Alan Kohler  abc.net.au
    5. ASX tracks global shares lower after glitch  CommBank

    Continue Reading

  • Indian Rupee Falls Past 90 Per Dollar as Trade Stalemate Weighs – Bloomberg.com

    1. Indian Rupee Falls Past 90 Per Dollar as Trade Stalemate Weighs  Bloomberg.com
    2. Rupee hits all-time low, holds above 90/USD mark with central bank help  Reuters
    3. Indian rupee may extend losses despite RBI’s move to hold the line at 90  Business Recorder
    4. USDINR trading to new all-time highs. What levels are key from a technical perspective?  TradingView
    5. INDIA RUPEE-Rupee set to hold near 90 with shaky sentiment, flows overshadowing dollar dip  MarketScreener

    Continue Reading

  • A 70-year-old pregnancy drug just revealed a hidden weakness in brain cancer

    A 70-year-old pregnancy drug just revealed a hidden weakness in brain cancer

    Over the last 70 years, hydralazine has been an indispensable tool in medicine — a front-line defense against life-threatening high blood pressure, especially during pregnancy. But despite its essential role, a fundamental mystery has persisted:…

    Continue Reading

  • A 70-year-old pregnancy drug just revealed a hidden weakness in brain cancer

    A 70-year-old pregnancy drug just revealed a hidden weakness in brain cancer

    Over the last 70 years, hydralazine has been an indispensable tool in medicine — a front-line defense against life-threatening high blood pressure, especially during pregnancy. But despite its essential role, a fundamental mystery has persisted:…

    Continue Reading

  • US cancels citizenship ceremonies for migrants from travel ban countries

    US cancels citizenship ceremonies for migrants from travel ban countries

    The US has halted the processing of all immigration applications linked to 19 countries already subject to a travel ban, according to an internal official memo seen by BBC partner CBS News.

    Immigration agents have been told to “stop final…

    Continue Reading